{"id":"restricted-opioid-prescribing","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL440626","moleculeType":"Small molecule","molecularWeight":"1268.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is not a drug but rather a prescribing protocol and institutional policy implemented at Walter Reed National Military Medical Center to minimize opioid exposure and dependence. It involves evidence-based guidelines for appropriate opioid use, dose limitations, and preference for non-opioid or multimodal pain management strategies. The approach aims to balance pain control with public health concerns regarding opioid-related harms.","oneSentence":"Restricted opioid prescribing is a clinical policy and practice guideline that limits the use of opioid medications to reduce the risk of addiction, overdose, and adverse outcomes.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:04:46.552Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Reduction of opioid-related adverse events and addiction risk in military healthcare settings"},{"name":"Chronic and acute pain management with non-opioid alternatives"}]},"trialDetails":[{"nctId":"NCT03461874","phase":"NA","title":"ACT Therapy for HF Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-03-15","conditions":"Migraine Without Aura","enrollment":64},{"nctId":"NCT06731348","phase":"PHASE4","title":"Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Walter Reed National Military Medical Center","startDate":"2024-12-01","conditions":"Patient Satisfaction, Opioid Use After Surgery, Urogynecologic Surgery","enrollment":92},{"nctId":"NCT03808025","phase":"NA","title":"Opioid Use in Shoulder Arthroplasty Patients: A Stratification and Algorithm","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2019-01-21","conditions":"Opioid Use","enrollment":10},{"nctId":"NCT04277975","phase":"NA","title":"Liberal vs. Restricted Post-discharge Opioid Prescribing Following Midurethral Sling","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2020-06-01","conditions":"Postoperative Pain, Opioid Use","enrollment":84}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":170,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"restricted opioid prescribing","genericName":"restricted opioid prescribing","companyName":"Walter Reed National Military Medical Center","companyId":"walter-reed-national-military-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Restricted opioid prescribing is a clinical policy and practice guideline that limits the use of opioid medications to reduce the risk of addiction, overdose, and adverse outcomes. Used for Reduction of opioid-related adverse events and addiction risk in military healthcare settings, Chronic and acute pain management with non-opioid alternatives.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}